Insights

Clinical Pipeline Salvia BioElectronics is in clinical development for MySalvia Therapy, a personalized neuromodulation implant for resistant migraine, presenting a near-term B2B sales opportunity with hospitals and specialty clinics seeking innovative, drug-free relief options.

US EU Expansion Active in the United States and Europe with recent leadership announcements, highlighting potential channels for market entry, regulatory engagement, and strategic partnerships to accelerate clinical evaluation toward commercialization.

Financing Strength Series B financing of 60 million USD and a total funding around 95 million USD indicate strong investor confidence and potential for scaled product development, paving the way for customer-ready devices and early adopter programs.

Key Stakeholder Access Recent appointment of a new Chair of the Board signals a broadened U.S. leadership network, enabling direct engagement with large MedTech customers, payers, and distribution partners in the US market.

Tech and Compliance Readiness Existing tech stack and scalable cloud/ERP tools (SOLIDWORKS, AWS, Salesforce, SAP, Microsoft Dynamics) support enterprise-grade product development, manufacturing planning, and CRM for enterprise customers and streamline post-sale service contracts.

Similar companies to Salvia BioElectronics

Salvia BioElectronics Tech Stack

Salvia BioElectronics uses 8 technology products and services including SOLIDWORKS, Amazon Web Services, Microsoft SharePoint, and more. Explore Salvia BioElectronics's tech stack below.

Media & News

Salvia BioElectronics's Email Address Formats

Salvia BioElectronics uses at least 2 email formats:
Salvia BioElectronics Email FormatsExamplePercentage
First.Last@salvianeuro.comJohn.Doe@salvianeuro.com
97%
First.MiddleLast@salvianeuro.comJohn.MichaelDoe@salvianeuro.com
3%

Frequently Asked Questions

What is Salvia BioElectronics's official website and social media links?

Minus sign iconPlus sign icon
Salvia BioElectronics's official website is salviabioelectronics.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Salvia BioElectronics generate?

Minus sign iconPlus sign icon
As of August 2026, Salvia BioElectronics's annual revenue is estimated to be $1M - $10M.

What is Salvia BioElectronics's NAICS code?

Minus sign iconPlus sign icon
Salvia BioElectronics's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Salvia BioElectronics have currently?

Minus sign iconPlus sign icon
As of August 2026, Salvia BioElectronics has approximately 79 employees across 2 continents, including Europe and North America. Key team members include Ceo | Founder: H. M., Chief Innovation Officer | Founder: D. S. and Chief Financial Officer: J. S. Explore Salvia BioElectronics's employee directory with LeadIQ.

What industry does Salvia BioElectronics belong to?

Minus sign iconPlus sign icon
Salvia BioElectronics operates in the Medical Equipment Manufacturing industry.

What technology does Salvia BioElectronics use?

Minus sign iconPlus sign icon
Salvia BioElectronics's tech stack includes SOLIDWORKS, Amazon Web Services, Microsoft SharePoint, Salesforce, SAP, Microsoft 365, Microsoft Dynamics and Webflow.

What is Salvia BioElectronics's email format?

Minus sign iconPlus sign icon
Salvia BioElectronics's email format typically follows the pattern of First.Last@salvianeuro.com. Find more Salvia BioElectronics email formats with LeadIQ.

How much funding has Salvia BioElectronics raised to date?

Minus sign iconPlus sign icon
As of August 2026, Salvia BioElectronics has raised $95M in funding. The last funding round occurred on May 27, 2025 for $60M.

When was Salvia BioElectronics founded?

Minus sign iconPlus sign icon
Salvia BioElectronics was founded in 2017.
Salvia BioElectronics logo

Salvia BioElectronics

Medical Equipment ManufacturingNorth Brabant, Netherlands51-200 Employees

Salvia BioElectronics is a medical device company developing a neuromodulation therapy for resistant migraine. Its MySalvia Therapy relies on implantable, slim devices that target nerves linked to migraine and are activated by a button on a wearable controller. The system is designed for everyday life and is currently being evaluated in clinical studies, with activity in the United States and Europe.

Founded in 2017 and based in Eindhoven, North Brabant, Salvia positions itself as a mid-sized player in medical equipment manufacturing, pursuing expansion into related indications such as cluster headache. In September 2025, the company received the LEVEL UP award, reflecting progress in its neuromodulation program.

Section iconCompany Overview

NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2017
Employees
51-200

Section iconFunding & Financials

  • $95M

    Salvia BioElectronics has raised a total of $95M of funding over 6 rounds. Their latest funding round was raised on May 27, 2025 in the amount of $60M as a Series B.

  • $1M - $10M

    Salvia BioElectronics's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.